Myomo, inc. MYO.US Overview
MYO AI Analysis & Strategy
Analysis Conclusion
The stock has been awarded the top rating for its value, but its dividend score is below 2. If the company starts distributing dividends, it may yield even better investment results.
MYO Current Performance
-2.87%
Myomo, inc.
0.98%
Avg of Sector
0.83%
S&P500
MYO Key Information
MYO Financial Forecast
Unit : USD
MYO Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | -0.08 | 20% | 0% | 9.83M | 161.9% | 6.6% | -2.2% |
| 2024Q3 | -0.01 | 85.7% | -50% | 12.07M | 153.7% | 52.3% | -10.5% |
| 2024Q2 | -0.03 | 50% | 28.6% | 9.21M | 81.3% | -7% | -14.9% |
| 2024Q1 | -0.03 | 25% | -57.1% | 7.52M | 26.2% | 3.3% | -102.2% |
| 2023Q4 | -0.1 | 9.1% | 11.1% | 3.75M | 8.9% | -7.8% | -51.7% |
MYO Profile
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.